Letter by Brambilla et al Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality

Letter by Brambilla et al Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report”

Published:2021-06 Issue:6 Volume:41 Page:
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Brambilla Marta¹^ORCID,Canzano Paola¹^ORCID,Becchetti Alessia¹^ORCID,Tremoli Elena¹^ORCID,Camera Marina¹²^ORCID

Affiliation:

1. Centro Cardiologico Monzino IRCCS, Milan, Italy (M.B., P.C., A.B., E.T., M.C.).

2. Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy (M.C.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report

2. Multifaceted role of extracellular vesicles in atherosclerosis

3. Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?

4. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity

5. Prerequisites for the analysis and sorting of extracellular vesicle subpopulations by high-resolution flow cytometry

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19;Journal of Thrombosis and Haemostasis;2024-09

2. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles;Vascular Pharmacology;2022-08

3. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2;Frontiers in Immunology;2022-06-17